Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Healthcare Advertising Agencies
Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Mydecine Innovations Group Inc
Bullboard Posts
User Avatar Image
(4)
•••
Comment by Losingmoneyon Nov 25, 2016 1:56pm
70 Views
Post# 25514671

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:.245

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:.245
divot111 wrote: Do the DD bud. You will see why I told you. I also told others about NF before it got over bloated on hype. Penny stocks run on momentum and the momentum will be at v.nu shortly. Momentum has currently left NF. Make money on the run ups. Don't hang on and watch it all disapear. Until others learn to not fall in love with penny stock stories they will never profit from penny stocks.


If people had listened to you two weeks ago, they wouldve missed out on 200-400% profit depending on where they bought in on this stock. So stfu, and get lost, go to NU, their volume is super sweet man. Pathetic loser, I hate people like you. You're what's wrong with the investment world. Just a piece of trash hoping to scare people and get them into their stock which is plummeting and youre trying to save it. So pathetic man, get a life.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities